TDC
LGND icon

Thompson Davis & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Thompson Davis & Co’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-248
Closed -$21K – 899
2017
Q3 		$21K Buy
+248
New +$21K 0.04% 466